NatureWise Biotech & Medicals Balance Sheet Health
Financial Health criteria checks 6/6
NatureWise Biotech & Medicals has a total shareholder equity of NT$623.3M and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$685.6M and NT$62.3M respectively. NatureWise Biotech & Medicals's EBIT is NT$11.4M making its interest coverage ratio -2.3. It has cash and short-term investments of NT$517.4M.
Key information
0%
Debt to equity ratio
NT$0
Debt
Interest coverage ratio | -2.3x |
Cash | NT$517.41m |
Equity | NT$623.28m |
Total liabilities | NT$62.34m |
Total assets | NT$685.62m |
Recent financial health updates
No updates
Recent updates
Lacklustre Performance Is Driving NatureWise Biotech & Medicals Corporation's (GTSM:4732) Low P/E
Apr 29A Look At The Intrinsic Value Of NatureWise Biotech & Medicals Corporation (GTSM:4732)
Mar 25Here's Why We Don't Think NatureWise Biotech & Medicals's (GTSM:4732) Statutory Earnings Reflect Its Underlying Earnings Potential
Dec 20Financial Position Analysis
Short Term Liabilities: 4732's short term assets (NT$614.5M) exceed its short term liabilities (NT$53.4M).
Long Term Liabilities: 4732's short term assets (NT$614.5M) exceed its long term liabilities (NT$8.9M).
Debt to Equity History and Analysis
Debt Level: 4732 is debt free.
Reducing Debt: 4732 has not had any debt for past 5 years.
Debt Coverage: 4732 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 4732 has no debt, therefore coverage of interest payments is not a concern.